Werewolf Therapeutics, Inc.
HOWL
$1.28
$0.043.23%
NASDAQ
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -92.10% | -0.53% | |||
| Gross Profit | 92.10% | 0.53% | |||
| SG&A Expenses | -8.83% | -28.76% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -2.50% | -11.58% | |||
| Operating Income | 2.50% | 11.58% | |||
| Income Before Tax | 0.59% | 11.33% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 0.59% | 11.33% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 0.59% | 11.33% | |||
| EBIT | 2.50% | 11.58% | |||
| EBITDA | 2.44% | 11.76% | |||
| EPS Basic | 0.92% | 12.03% | |||
| Normalized Basic EPS | 0.91% | 12.03% | |||
| EPS Diluted | 0.87% | 12.03% | |||
| Normalized Diluted EPS | 0.91% | 12.03% | |||
| Average Basic Shares Outstanding | 0.34% | 0.78% | |||
| Average Diluted Shares Outstanding | 0.34% | 0.78% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||